<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04907955</url>
  </required_header>
  <id_info>
    <org_study_id>02282021065727</org_study_id>
    <nct_id>NCT04907955</nct_id>
  </id_info>
  <brief_title>Visual Performance Following Implantation of Presbyopia Correcting IOLs</brief_title>
  <official_title>Visual Performance Following Implantation of 3 Presbyopia Correcting Intraocuar Lenses</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Dar Al Shifa Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Dar Al Shifa Hospital</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of the current study was to compare the visual performance after bilateral&#xD;
      implantation of the Panoptix IOL , or the AT LISA IOL or Tecnis Symfony IOL . The focus was&#xD;
      on intermediate vision, defocus curves, and contrast sensitivity.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">June 1, 2019</start_date>
  <completion_date type="Actual">May 30, 2020</completion_date>
  <primary_completion_date type="Actual">May 30, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>visual acuity</measure>
    <time_frame>6 months postoperatively.</time_frame>
    <description>The monocular uncorrected (UDVA) and corrected (CDVA) distance visual acuity (4 m), uncorrected intermediate visual acuity (UIVA) (60 cm and 80 cm), distance-corrected intermediate visual acuity (DCIVA), uncorrected near visual acuity (40 cm), and distance-corrected near visual acuity (DCNVA) were assessed. Standardized logarithm of the minimum angle of resolution (logMAR) charts were used for visual acuity measurement at 4 m, 80 cm, and 40 cm.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>defocus curve</measure>
    <time_frame>6 months postoperatively.</time_frame>
    <description>The binocular defocus curve was done to evaluate the functional range of vision. The curve was obtained while the patient wearing his distance correction to provide the best distance visual acuity in both eyes. The test was performed under photopic conditions (85 candelas/m2) using ETDRS charts at a distance of 4m with the introduction of defocusing lenses from +1.00 D to -4.00 D in 0.50 D steps.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>contract senstivity</measure>
    <time_frame>6 months postoperatively.</time_frame>
    <description>The CSV-1000 system (Vector Vision Inc. Greenville, OH, USA) was used to measure contrast sensitivity under photopic and mesopic conditions without glare with spatial frequencies ranging between 3 and 18 cycles/degree.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>photic phenomena</measure>
    <time_frame>6 months postoperatively.</time_frame>
    <description>The presence of dysphotopsia including haloes, glare and starburst were assessed regarding their frequency, severity and the degree of bother.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>spectacle independence</measure>
    <time_frame>6 months postoperatively.</time_frame>
    <description>patients were given a questionnaire to assess their spectacle independence. The response for spectacle independence was yes or no.</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">50</enrollment>
  <condition>Loss of Visual Contrast Sensitivity</condition>
  <condition>Near Vision</condition>
  <condition>Visual Impairment</condition>
  <arm_group>
    <arm_group_label>panoptix PANFOCAL intraocular lens</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>panoptix PANFOCAL intraocular lensis a single-piece aspheric non-apodized diffractive panfocal IOL that distributes light energy to three focal points in both small and large pupil conditions</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Trifocal Diffractive the AT LISA intraocular lens</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Trifocal Diffractive the AT LISA is a preloaded single-piece aspheric diffractive trifocal IOL and made of hydrophilic acrylic with a hydrophobic surface with an ultraviolet absorber. This aspheric IOL is aberration -correcting in order to reduce and compensate for corneal spherical aberrations.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Symphony EDOF (extended depth of focus) intraocular lens</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>SYMPHONY EDOF intraocular lens is a single-piece aspheric biconvex hydrophobic acrylic IOL with a 6.0 mm optic and an 13.0 mm overall diameter. This IOL consists of a wavefront-designed anterior aspheric surface (negative spherical aberration of -0.27 mm to counterbalance the net positive spherical aberration from cornea) and a posterior achromatic diffractive surface with echelette design.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>phacoemulsification with implantation of presbyopia correcting IOL</intervention_name>
    <description>cataract extraction with phacoemulsification and insertion of presbyopia correcting IOL</description>
    <arm_group_label>Symphony EDOF (extended depth of focus) intraocular lens</arm_group_label>
    <arm_group_label>Trifocal Diffractive the AT LISA intraocular lens</arm_group_label>
    <arm_group_label>panoptix PANFOCAL intraocular lens</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  patients with normal ocular examination apart from cataract.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  previous ocular surgery.&#xD;
&#xD;
          -  ocular pathology or corneal abnormalities.&#xD;
&#xD;
          -  an endothelial cell count below 2000 cells/mm2.&#xD;
&#xD;
          -  corneal astigmatism greater than 1.0 diopter (D) measured with Scheimpflug tomography&#xD;
             (Sirius, CSO, Italy).&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Daralshifa hospital</name>
      <address>
        <city>Kuwait</city>
        <country>Kuwait</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Kuwait</country>
  </location_countries>
  <verification_date>May 2021</verification_date>
  <study_first_submitted>May 21, 2021</study_first_submitted>
  <study_first_submitted_qc>May 25, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">June 1, 2021</study_first_posted>
  <last_update_submitted>May 25, 2021</last_update_submitted>
  <last_update_submitted_qc>May 25, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">June 1, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Dar Al Shifa Hospital</investigator_affiliation>
    <investigator_full_name>magda torky</investigator_full_name>
    <investigator_title>Principle investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vision Disorders</mesh_term>
    <mesh_term>Vision, Low</mesh_term>
    <mesh_term>Presbyopia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

